|

Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine

RECRUITINGSponsored by Sinovac Biotech Co., Ltd
Actively Recruiting
SponsorSinovac Biotech Co., Ltd
Started2026-08-02
Est. completion2026-11-30
Eligibility
Age21 Years – 28 Years
Healthy vol.Accepted

Summary

This study is a single-center, open-label, controlled study. Its primary objective is to evaluate the 20-year persistence of immunity induced by the inactivated hepatitis A vaccine. At least 106 healthy participants aged 21-28 years will be enrolled. Participants will be selected from individuals who completed the full vaccination course in the PRO-HA-4006 clinical study (Three-Batch Consistency Study of Healive® in Healthy Children Aged 1-8 Years in Changzhou) . After voluntarily providing informed consent, each participant will undergo one venous blood collection of approximately 3.0 mL for hepatitis A antibody testing to assess the persistence of immunity induced by the hepatitis A vaccine.

Eligibility

Age: 21 Years – 28 YearsHealthy volunteers accepted
Inclusion Criteria:

Participants must meet all of the following criteria to be eligible for this study:

1. Healthy participants aged 21-28 years who previously participated in PRO-HA-4006 and completed the full vaccination course;
2. Participants who are able to understand and voluntarily sign the informed consent form;
3. Provision of valid legal identification.

Exclusion Criteria:

Individuals meeting any of the following criteria will be excluded from this study:

1. History of hepatitis A virus infection;
2. Receipt of any vaccine containing hepatitis A antigen since participation in the PRO-HA-4006 clinical study;
3. Autoimmune disease or immunodeficiency/immunosuppression;
4. Coagulation abnormalities, such as coagulation factor deficiency or platelet abnormalities, or a history of significant bleeding, hematoma, or ecchymosis following intramuscular injection or venipuncture;
5. In the investigator's judgment, any other factor that makes the participant unsuitable for participation in the clinical study.

Conditions2

Hepatitis ALiver Disease

Interventions2

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.